Redouble AI is the solution to scale human-in-the-loop for AI workflows in regulated industries. Instead of having to rely on slow and expensive human reviewers, Redouble’s clients save 80% of staff costs and significantly improve the accuracy and quality of their outputs by integrating our tool into their workflows. Addressing an $11BN market, the company is already generating revenue with its first set of clients. The founders are two serial entrepreneurs (who have built successful companies in AI and health-tech respectively) and a data engineering veteran who has written more than 120 enterprise-grade software applications.
Martin Bittner is the Co-Founder & CEO of Redouble AI. Before that, he was the CEO of Arctoris, a pharma workflow automation company which he co-founded and led from inception to profitability. In terms of background, Martin is a physician-scientist, having obtained his MD from the University of Freiburg in Germany, and his DPhil in Oncology as a Rhodes scholar at the University of Oxford.
Haotian received his training in physics and computational chemistry from Zhejiang University and New York University. In 2017 Haotian cofounded the AI drug discovery start-up Redesign Science as CTO, designed and built the internal computational pipeline that increased the high through put screening efficiency by 100X.
Andrey has spent 25 years in data and software engineering across Novartis and several startups. Specializing in devising and executing holistic data and software strategies, he led the development of over 120 software, data and AI applications, contributing to the successful market introduction of seven pharmaceutical products
TL;DR: Redouble is the solution to scale human-in-the-loop for AI workflows in regulated industries.
Companies are increasingly adopting LLMs to automate their workflows, but sufficiently accurate and consistent outputs are hard to obtain, especially in regulated industries where mistakes are costly. As a result, AI companies are using human reviewers in production to verify and correct the output of their AI pipelines.
This human review step quickly becomes a critical bottleneck for exponential growth:
Production-level quality control in regulated industries is an inherently different problem from model performance evaluation, since one cannot optimize the prompts to cover all the edge cases nor prevent all the unacceptable variations in LLM output.
Redouble AI is purpose-built to operate within these “high stakes, few data points” areas.
To address the problems above, our solution:
In addition, we also surface succinct, actionable, and granular insights that can be used to further optimize your AI workflow. So you can continually improve your pipeline’s performance as you scale.
We understand that human-in-the-loop quality control is critical if you are working with AI in the legal, healthcare, insurance, or finance sectors. We are on a mission to ensure that AI can be safely used in these mission-critical spaces without breaking the bank.
We are looking for companies that provide LLM-based services in regulated industries and use human reviewers. If you use human reviewers in your AI workflow, or if you know people who do, we would greatly appreciate any introductions and will offer any help that we can in return.
Schedule a demo on Redouble.ai or reach us through founders@redouble.ai
Martin is a serial entrepreneur, Rhodes scholar, and MD-PhD by training. In his last venture as co-founder and CEO, he built a profitable tech-enabled life sciences company and raised over $15M in venture funding.
Haotian is a serial entrepreneur, engineer, and physicist by training. In his last venture as co-founder and CTO, he built an AI-driven biotech company and raised over $17M in venture funding.
Andrey is a software and data engineer and mathematical statistician by training. During his 25 years at Novartis and multiple startups, he has built more than 100 applications across software and data infrastructure.